Breaking: Young boy dies in trial for Pfizer Duchenne gene therapy

Pfizer said it had not yet determined precisely what happened or how the boy died.

May 7, 2024 Check out STAT+

Sponsored By

Mark Lennihan/AP STAT+ | Young boy dies in trial for Pfizer Duchenne gene therapy The boy had received the therapy for Duchenne muscular dystrophy in a trial for boys aged 2 or 3. Pfizer is pausing its trial in older boys. By Jason Mast WHO's top scientist learned a hard lesson about H5N1 two decades ago: Stopping it takes more than biology The World Health Organization's chief scientist, Jeremy Farrar, said the social context is key in responding to disease threats like H5N1. By Helen Branswell STAT+ | House panel eyes PBM reform to pay for telehealth extensions A new bill includes extension of more flexible rules for telehealth and hospital home-care programs. It also has new limits on drug middlemen. By Mario Aguilar and Rachel Cohrs Zhang Courtesy Emmi S. Herman Opinion: Measles is coming back. My sister Marcie isn't Children's author Emmi S. Herman on the terrible impact that measles had on her family. "I think about Marcie every day." By Emmi S. Herman Opinion: As livestock move around the country, so does H5N1. The U.S. needs real-time tracking of livestock movements The presence of H5N1 bird flu virus in livestock in one state means its presence in others, given how livestock are moved around the U.S. By Shweta Bansal and Colleen Webb STAT+ | Assistants, not replacements: How AI can accelerate research and health care At the Milken Institute 2024 Global Conference, leaders in health care technology debated the best way to develop and regulate AI in medicine. By Brittany Trang Milken Institute STAT+ | Life science leaders on how to make drug development less expensive, slow, and risky The pace of future therapeutic successes will depend on whether the industry can streamline and rethink drug development. By Jonathan Wosen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser